Medtronic Cardiac Software Receives FDA Clearance and CE Mark

Medtronic announced its Affera™ Prism-2 Mapping Software has received FDA clearance and CE Mark, enhancing cardiac mapping capabilities. Additionally, the PulseSelect ProxBox™ Adapter with Proximity Indicator software secured CE Mark, offering real-time tissue proximity feedback. These regulatory approvals are significant for advancing the company's cardiac ablation technologies, potentially improving patient outcomes in heart rhythm disorders.